Fall 2017

Demystifying Veterinary Clinical Trials

A veterinary oncologist explains the ins and outs of experimental studies.

By Genevieve Rajewski

Previous Next

As in human health, participation in veterinary clinical trials is always voluntary. Photo: Alonso Nichols

When people want the best care for a serious illness, they often seek out a cutting-edge research and teaching hospital. But what pet owners may not know, is that similar options are available in veterinary medicine. Each year at Cummings Veterinary Medical Center, nearly 500 animals participate in clinical trials, with upwards of 30 studies enrolling patients at any given time.

Yet because clinical trials often test therapies before it is known how well they may work, there are often misconceptions and confusion about the process of enrolling an animal in a study. Here, Cheryl London, V90, a veterinary medical oncologist and director of the new Clinical Trials Office at Cummings School, addresses some common myths about trials and explains how they really work.

Myth #1: My pet will be a test subject

As in human health, participation in veterinary clinical trials is always voluntary. If a trial might help, experts explain the potential risks and benefits, any diagnostics or procedures involved, and all the financial considerations. Pet owners then review and sign a consent form detailing the study’s goals.

While the study is ongoing, three veterinary technicians (nurses) with more than 50 years of cumulative experience, along with veterinary doctors, monitor each participating pet’s health closely. “The safety of our patients is the most important thing to us, and owners are encouraged to ask us lots of questions along the way,” said London.

And owners can always remove an animal from a study at any time, she said. “So once you start a trial with your pet, you don’t have to finish if you are unhappy with how treatment is progressing. Also, we will remove an animal from a clinical trial if we believe it is not of any benefit to continue or there are unacceptable side effects.”

Myth #2: Clinical trials are too risky

Clinical studies are made available to Cummings School patients only after initial studies have determined that the treatment is safe. “Unlike clinical trials in human medicine, in which a drug or device sometimes may have never been tested in people before, we have a lot of safety data before we try anything in our patients,” London said. “So the risk to pets from participating is relatively low.”

Many veterinary clinical trials are “open label”—meaning pet owners know the exact drug on trial—and also not placebo-controlled. That means, for example, that the pet doesn’t get a sugar pill in place of the promising drug. Sometimes pets undergo the current standard therapy for their illness, in addition to the experimental therapy that researchers hope will improve outcomes.

Myth #3: Participation is too expensive

Many people don’t have health insurance for their pets, and paying out of pocket for advanced care can be a financial burden. “Clinical trials may offer the opportunity to access state-of-the-art care at little to no cost,” London said. “The majority of our studies offer some sort of financial support—in many cases, they’re completely free.”

Often, there’s also a reimbursement in the form of an “in-store credit” for participating in a study. For example, a dog with a soft-tissue sarcoma might receive immunotherapy in a study and then, after blood tests and a biopsy, the owner could receive $2,000 toward the removal of the dog’s tumor. The goal is to defray a significant part of the typical cost for the standard treatment.

Myth #4: Clinical trials are only for treating cancer

Clinical trials are available for a wide variety of diseases in smaller animals, such as dogs and cats, as well as horses and farm animals. Trials now ongoing at Cummings School include those advancing our understanding of cardiac conditions, kidney and liver diseases, arthritis, skin and orthopedic problems, and neurological conditions.

You can find open studies at Cummings School through its clinical trial website and search for other available studies through the American Veterinary Medical Association’s Animal Health Studies Database.

Myth #5: Clinical trials aren’t available nearby

While geographic proximity is important, pet owners might have more options than they realize—some studies have as many as 10 participating sites nationwide. And to mitigate the strain of travel on owners, researchers can sometimes partner with a specialty practice closer to the homes of animal owners.

Myth #6: Trials only help a small number of pets

Owners often initially seek out clinical trials for their sick pets in hopes that they will benefit from a cutting-edge treatment before it is widely available. But there’s another benefit that often becomes a source of pride: Being involved with research means playing an essential part in advancing science that can improve the well-being of all animals—and possibly the well-being of people, too. “Often our clinical trials have a dual purpose in that we don’t just learn something new about animal health; we advance of our understanding of human health as well,” London said. “It’s a win-win.”


The Promise of Immunotherapy

Two new clinical trials at Cummings School seek to advance the development of promising new therapies that use the body’s immune system to fight cancer. The work is funded by more than $5 million in grants from the National Cancer Institute of the National Institutes of Health through the Cancer Moonshot initiative—and part of a larger effort to study how immune therapies work in dogs with naturally occurring cancer to improve similar approaches in people.

The first grant is a collaborative effort between Tufts and Cornell University to evaluate new combinations of immune therapies for treating canine B cell lymphoma, one of the most common tumors in dogs. As canine and human B cell lymphoma are closely related, the goal is to develop a chemotherapy-free treatment regimen that results in long-term survival in dogs, and then use these findings to design future human clinical trials.

The second grant is a collaborative effort between Tufts and Colorado State University focused on osteosarcoma, a bone cancer in both dogs and children, for which no therapeutic improvements have occurred in over 30 years. The purpose of this work is to screen the effectiveness of four new immunotherapy drug combinations in treating and ultimately preventing spread of osteosarcoma to the lungs.

For more information on clinical trials, email clinicaltrials@tufts.edu.

Top Stories

Sleep Tight

What you’ll want to know about anesthesia, whether your pet’s procedure is risky or routine

From Classroom to Clinic

We asked five students from Cummings School’s Class of 2017 to tell us about the excitement, anxiety and pride of beginning their clinical rotations

The Hurt Unlocker

Your pet can’t tell you he’s in pain, but the way he behaves can say plenty about how he’s feeling

Editor's Picks

The Grief Counselor Is In

Three questions for Eric Richman, Cummings School's first veterinary social worker.

How Dogs Think

A scientist explores how genetics and experience shape the canine mind.

The Campus Buzz

A new selective in honeybee medicine is preparing veterinarians to work with beekeepers.